Dr Cheryl Blanchard, president and CEO of Anika Therapeutics, discusses the company, technology and deve...
US Orthobio market shines bright for the first quarter of 2023. The US Orthobiologics (Orthobio) market ...
Some HA players navigate through smooth river flows, while others hit turbulent whitewater. For Q422, CM...
Total Orthobio market bouncing back and coming through 2022 smelling like a rose for the 2nd year in a r...
PRP and Adipose Through the Looking Glass The interest and demand for regenerative medicine for various ...
CMS Reimbursement changes raging like a beast to belabor several HA market players For Q322, the true im...
Highlighting the latest research, technology developments and innovations taking place in orthobiologics...
Mr J. David Owens, President & CEO of BiologicsMD, and Chief Scientific Officer, Dr. Robyn Goforth, ...
US Viscosupplementation Market players march on the positive momentum of Q421 and Q122, putting the spri...
From the impact of stringent regulations to the shift toward new indications and rising market segments,...
Login